Streetbeat News

Earnings

CADE

Cadence Bank reported Q3 earnings of $0.73 per share, beating estimates of $0.64, marking a 30.36% increase from last year. However, sales of $447.36M missed the $450.96M estimate, showing a slight decrease from last year's $448.02M.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:34 pm

SSD

Simpson Manufacturing Co (NYSE:SSD) has announced its financial estimates for FY 2024, projecting an operating margin between 19.0% and 19.5%, and capital expenditures between $175 million and $185 million.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:33 pm

ELS

Equity Lifestyle Properties has provided its financial outlook for FY24 and Q4. The company expects FY24 normalized funds from operations (FFO) to be between $2.89 and $2.95, aligning with the current estimate of $2.89. For Q4, the expected normalized FFO is between $0.73 and $0.79.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:33 pm

FLXS

Flexsteel Industries reported strong Q1 earnings, with EPS of $0.74 beating estimates by 19.35% and sales of $104.01M surpassing expectations by 2.37%. This marks a significant improvement from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:31 pm

IRTC

MEDP

SNSE

In Monday's after-market session, several health care stocks experienced significant price movements. iRhythm Technologies (IRTC) saw a notable increase of 16.6%, while Sensei Biotherapeutics (SNSE) faced a sharp decline of 20.5%. Medpace Holdings (MEDP) also dropped by 12.17% following their Q3 earnings release.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:31 pm

NUE

Nucor (NYSE:NUE) reported Q3 2024 earnings per share of $1.49, surpassing the analyst estimate of $1.47. The company's sales were $7.44 billion, exceeding the expected $7.28 billion, despite a 15.22% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:31 pm

ELS

Equity Lifestyle Properties has provided guidance for its fiscal year 2024 adjusted EPS to be between $1.89 and $1.95, which is below the estimated $1.96. Additionally, the company expects its Q4 adjusted EPS to range from $0.44 to $0.50.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:31 pm

MEDP

Medspace has revised its FY24 revenue guidance to $2.090B-$2.130B, which is below the previous estimate of $2.138B. However, the company expects its GAAP EPS to be between $11.71 and $12.09, surpassing the earlier estimate of $11.56.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:27 pm

MEDP

Medpace Holdings shares declined following the release of disappointing Q3 sales results.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:27 pm

SIGI

Selective Insurance Group (NASDAQ:SIGI) has revised its GAAP combined ratio guidance for 2024 to 102.5%, up from the previous 101.5%. This indicates a potential increase in costs relative to premiums earned.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:27 pm